| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/10/2006 | WO2006069142A3 Methods for determining cellular response to stimuli |
| 08/10/2006 | WO2006067572A3 A method for diagnosing and monitoring cellular reservoirs of disease |
| 08/10/2006 | WO2006067565A3 Truncated gabab receptor and methods of use thereof |
| 08/10/2006 | WO2006066912A3 Detection of a therapeutic antibody in an experimental animal |
| 08/10/2006 | WO2006066649A3 Oil composition for lubricating an egr equipped diesel engine and an egr equipped diesel engine comprising same |
| 08/10/2006 | WO2006063452B1 Ex vivo verification of biopsy tissue samples |
| 08/10/2006 | WO2006062701A3 Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene |
| 08/10/2006 | WO2006061610A3 Diagnosis of neurodegenerative diseases |
| 08/10/2006 | WO2006060335A3 Cellular signaling pathway based assays, reagents and kits |
| 08/10/2006 | WO2006059258A3 Excitation and measurement method for a magnetic biosensor |
| 08/10/2006 | WO2006059069A3 Ion channel |
| 08/10/2006 | WO2006058778A3 Luminescent indicator dye and optical sensor |
| 08/10/2006 | WO2006054326B1 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity |
| 08/10/2006 | WO2006049777A3 Nucleic acid sequences encoding luciferase for expression in filamentous fungi |
| 08/10/2006 | WO2006044413B1 Methods for forming dyed microspheres and populations of dyed microspheres |
| 08/10/2006 | WO2006042811A3 A sensor film for transcutaneous insertion and a method for making the sensor film |
| 08/10/2006 | WO2006040142A3 Method for detecting and/or determining the concentration of at least one ligand |
| 08/10/2006 | WO2006034239A3 Antimicrobial mesoporous silica nanoparticles |
| 08/10/2006 | WO2006028634A3 Site specific pegylation of broadly-neutralizing antibodies against hepatitis c virus and their use in the treatment of chronic hcv infections |
| 08/10/2006 | WO2006027147A3 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 08/10/2006 | WO2006026608A3 Transgenic mammals and cell lines for the identification of glutamate transporter modulators |
| 08/10/2006 | WO2006025887A3 Long wavelength thiol-reactive fluorophores |
| 08/10/2006 | WO2006021811A3 Treatment of posterior capsule opacification |
| 08/10/2006 | WO2006021691A8 Method and device for biomass determination in a medium, in particular a medium containing biological cells, and measurement apparatus implementing said method |
| 08/10/2006 | WO2006016051A3 Device with removal member for detecting an analyte in a liquid sample |
| 08/10/2006 | WO2006010533A3 Pancreatic polypeptide as target/marker of beta cell failure |
| 08/10/2006 | WO2006009860A3 Methods for identifying stem cells based on nuclear morphotypes |
| 08/10/2006 | WO2006005585A3 Secreted polypeptide species differentially expressed during pregnancy |
| 08/10/2006 | WO2006000576A3 Methods and compositions to promote bone homeostasis |
| 08/10/2006 | WO2005118621A3 Omi pdz modulators |
| 08/10/2006 | WO2005115455A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 08/10/2006 | WO2005113791A3 Methods of identifying modulators of bacterial type iii protein secretion system |
| 08/10/2006 | WO2005103716A3 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 08/10/2006 | WO2005099337A3 Therapeutic peptides |
| 08/10/2006 | WO2005086770A3 Methods for genetic analysis |
| 08/10/2006 | WO2005086634A3 A secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 08/10/2006 | WO2005078124A3 Diagnostic marker for cancer |
| 08/10/2006 | WO2005069724A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | WO2005022122A3 Indirect measurement of diluents in a multi-component natural gas |
| 08/10/2006 | WO2005001417A3 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof |
| 08/10/2006 | WO2004096979A3 Methods and systems for annotating biomolecular sequences |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | WO2004037848A3 Process for determining target function and identifying drug leads |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179501 Transgenic mice expressing human cd20 |
| 08/10/2006 | US20060179497 Methods to treat conditions associated with insulin signaling dysregulation |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060179494 Non-human animal exhibiting bone metastasis of tumor cells |
| 08/10/2006 | US20060178914 Remote health monitoring and maintenance system |
| 08/10/2006 | US20060178842 Methods and computer products for predicting nucleic acid hybridization affinity |
| 08/10/2006 | US20060178841 Integrated biosensor and simulation system for diagnosis and therapy |
| 08/10/2006 | US20060178836 System and method for adaptive bolus chasing computed tomography (CT) angiography |
| 08/10/2006 | US20060178690 Tissue penetration device |
| 08/10/2006 | US20060178689 Tissue penetration device |
| 08/10/2006 | US20060178688 Tissue penetration device |
| 08/10/2006 | US20060178687 Tissue penetration device |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178327 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178292 Methods and compositions of ecdysozoan molt inhibition |
| 08/10/2006 | US20060177945 Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
| 08/10/2006 | US20060177944 RI-labeled compound synthesizing system |
| 08/10/2006 | US20060177943 Method of inhibiting nonspecific interaction between molecules on solid phase support |
| 08/10/2006 | US20060177938 Method for analyzing protein and protein analysis reagent to be used therein |
| 08/10/2006 | US20060177937 Interrogation zone, photo diode, light impingement and collection path, amplifier circuit and oscillator that provides signals |
| 08/10/2006 | US20060177935 Modified freeze fracture direct imaging apparatus and technique |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177888 Method for evaluating antioxidation capability of organism sample |
| 08/10/2006 | US20060177887 Method of analyzing a protein |
| 08/10/2006 | US20060177884 Causing the 5-FU in the sample and a conjugate of a 5-FU and a carrier to bind with an antibody that reacts with 5-FU but does not react with tegafur and measuring the amount of bound or unbound conjugate |
| 08/10/2006 | US20060177883 5-Fluoro-uracil immunoassay |
| 08/10/2006 | US20060177882 Immunoassays with enhanced selectivity |
| 08/10/2006 | US20060177881 Antibodies against type A botulinum neurotoxin |
| 08/10/2006 | US20060177880 Use of PRN3/ILEU as a marker for colorectal cancer |
| 08/10/2006 | US20060177879 Magnetic nanoparticles and method of fabrication |
| 08/10/2006 | US20060177878 Animal cell colony picking apparatus and method |
| 08/10/2006 | US20060177877 Methods for identifying combinations of entities as therapeutics |
| 08/10/2006 | US20060177876 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip |
| 08/10/2006 | US20060177875 Tryptase polypeptide and uses thereof |
| 08/10/2006 | US20060177874 Target material need not be labelled; no signal processing required; signal can be directly decoded by confirming whether a current flows through the switch; biochips; miniaturization |
| 08/10/2006 | US20060177873 Method of adjusting the working range of a multi-analyte assay |
| 08/10/2006 | US20060177872 Using paramagnetic microparticles coated with a purified recombinant porcine intrinsic factor and chemiluminescence as capture and visualization tools in detection and quantification of vitamin B12 in sample |
| 08/10/2006 | US20060177871 Murine IL-18 crystal structure |
| 08/10/2006 | US20060177870 Immunoassays |
| 08/10/2006 | US20060177868 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array |
| 08/10/2006 | US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 08/10/2006 | US20060177865 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 08/10/2006 | US20060177864 Methods for identifying drug combinations for the treatment of proliferative diseases |
| 08/10/2006 | US20060177862 Ribosome display |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177855 Nanoparticles for manipulation of biopolymers and methods of thereof |
| 08/10/2006 | US20060177850 Particle-based multiplex assay system with three or more assay reporters |
| 08/10/2006 | US20060177835 A dual oligonucleotide hybridization assay combining the advantages of the direct detection assays (e.g., easy quantification and minimal risk of carry-over contamination) with the specificity provided by a dual oligonucleotide hybridization assay; site-specific nuclease cleavage by a variety of enzymes |
| 08/10/2006 | US20060177829 Contacting human beta-transducin repeat containing protein ( beta -TrCP) beta -TrCP1 or beta -TrCP2 with test compound and a phosphorylated cell division cycle 25A (Cdc25A) protein or a phosphorylated fragment thereof; detecting reduced binding compared to control; drug screening; anticarcinogenic agents |
| 08/10/2006 | US20060177814 Systemic lupus erythematosus |
| 08/10/2006 | US20060177813 Novel high-throughput screening method of drug for bioactive protein |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |